GLOBAL REACH LABS, LLC
NPI 1174167597
Clinical Medical Laboratory in Denver, CO

NPI Status: Active since October 29, 2019

Contact Information

3400 E BAYAUD AVE STE 280
DENVER, CO
ZIP 80209
Phone: (561) 373-0577

Get Directions Write a Review

  • Organization
  • Clinical Medical Laboratory
  • CLIA Number: 06D2173555
  • CLIA Cert. Type: Independent
  • CLIA Exp. Date: 12-28-2025

About GLOBAL REACH LABS, LLC

This page provides the complete NPI Profile along with additional information for Global Reach Labs, Llc, a provider established in Denver, Colorado operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1174167597 assigned on October 2019. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 3 years ago. The authorized official of this NPI record is Mr. Keith Gray (President)

NPI
1174167597
Provider Name
GLOBAL REACH LABS, LLC
Entity Type
Organization
Location Address
3400 E BAYAUD AVE STE 280 DENVER, CO 80209
Location Phone
(561) 373-0577
Mailing Address
PO BOX 850067 RICHARDSON, TX 75085
Mailing Phone
(561) 373-0577
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
10-29-2019
Last Update Date
10-18-2023
Code Navigator

Establishments like Global Reach Labs, Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.

Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinical Medical Laboratory

Taxonomy Code
291U00000X
Type
Laboratories
Taxonomy Description
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

MR. KEITH GRAY

Authorized Official Title
PRESIDENT
Authorized Official Phone
(561) 373-0577

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Automated urinalysis test

An automated urinalysis test is a routine examination that checks your urine for various substances. It can help identify potential health issues such as kidney problems or diabetes. The test uses a machine to analyze a small urine sample, providing quick and accurate results.

This service was performed 17 times for 17 patients

Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b

This test detects the presence of SARS-CoV-2 (COVID-19) and Influenza types A and B in your body. It uses a method called the multiplex amplified probe technique to amplify and identify specific virus genes. It helps in early diagnosis and appropriate treatment.

This service was performed 13 times for 13 patients

Detection test by nucleic acid for multiple organisms, amplified probe(s) technique

This is a test that identifies various microorganisms in your body using a method called amplified probe technique. It targets specific genetic material (nucleic acids) of the organisms, amplifying them for easy detection. This helps in diagnosing infections accurately.

This service was performed 42 times for 13 patients

Detection test by nucleic acid for organism, amplified probe technique

A nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.

This service was performed 182 times for 13 patients

Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique

A detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.

This service was performed 14 times for 13 patients

Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique

A detection test by nucleic acid for MRSA bacteria uses an amplified probe technique. It's a lab procedure that identifies the presence of MRSA, a type of bacteria resistant to many antibiotics. This test helps in deciding the best treatment.

This service was performed 14 times for 13 patients

Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique

This test detects Group A Streptococcus bacteria in your body. It uses an amplified probe technique, which amplifies the bacteria's nucleic acid, making it easier to identify. This test helps diagnose conditions like strep throat or scarlet fever.

This service was performed 14 times for 13 patients

Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique

A detection test by nucleic acid for Group B Strep uses an amplified probe technique. This test identifies the presence of Group B Strep bacteria in the body. It involves collecting a sample, usually a swab, which is then examined in a lab for the bacteria's genetic material.

This service was performed 14 times for 13 patients

Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique

The detection test by nucleic acid for vancomycin-resistant strep (VRE) is a laboratory procedure. It uses an amplified probe technique to identify specific genetic material in bacteria. This helps determine if the bacteria are resistant to the antibiotic vancomycin.

This service was performed 14 times for 13 patients

Detection test for candida species (yeast), amplified probe technique

This test helps identify Candida, a type of fungus often present in the human body. An amplified probe technique is used, which enhances detection of the fungus in a sample. This method increases the accuracy of the test, helping to determine the best treatment.

This service was performed 70 times for 13 patients

Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants

Gene analysis for 5,10-methylenetetrahydrofolate reductase (MTHFR) common variants is a test that looks at your DNA to identify any changes in the MTHFR gene. These changes can affect how your body processes certain vitamins, which could impact your overall health.

This service was performed 34 times for 34 patients

Gene analysis (adenomatous polyposis coli), full gene sequence

Gene analysis of the adenomatous polyposis coli (APC) involves studying the entire sequence of the APC gene. This test helps identify mutations that could lead to conditions like familial adenomatous polyposis. The procedure is non-invasive and uses a blood sample.

This service was performed 44 times for 44 patients

Gene analysis (bloom syndrome, recq helicase-like)

Gene analysis for Bloom Syndrome involves studying the RECQ helicase-like gene. This gene is responsible for DNA repair. When it's not working properly, it can lead to Bloom Syndrome, a condition that increases the risk of developing various types of cancer.

This service was performed 33 times for 33 patients

Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants

Gene analysis for breast cancer 1 and 2 involves studying your DNA to detect alterations that may increase your risk of developing certain health issues. This test analyzes the full sequence and checks for duplication or deletion variants.

This service was performed 30 times for 30 patients

Gene analysis (coagulation factor ix) full sequence analysis

Gene analysis for coagulation factor IX is a process that examines your genes, specifically the one responsible for factor IX - a protein that helps blood clot. It can detect any changes or mutations in this gene, which could affect your body's ability to control bleeding.

This service was performed 1,600 times for 1,598 patients

Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence

Gene analysis for cystic fibrosis involves examining the entire CFTR gene to identify any changes or mutations that could cause the disease. This can help in diagnosing and managing the condition effectively.

This service was performed 33 times for 33 patients

Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants

Gene analysis of cytochrome P450 2D6 (CYP2D6) common variants involves studying specific genes to understand your body's ability to process certain medications. This can help tailor treatments to your unique genetic makeup, optimizing medication effectiveness and safety.

This service was performed 24 times for 24 patients

Gene analysis (fanconi anemia, complementation group c) common variant

Gene analysis for Fanconi Anemia, Complementation Group C, is a test that looks at your DNA to see if you have changes in a specific gene linked to this type of anemia. This can help determine if you have the condition or if you might pass it on to your children.

This service was performed 32 times for 32 patients

Gene analysis (frataxin) of full sequence

Gene analysis of frataxin involves studying the entire sequence of the frataxin gene. This test helps identify any changes or mutations in the gene that may cause health issues, such as Friedreich's ataxia. It's a non-invasive procedure using a blood sample.

This service was performed 11 times for 11 patients

Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants

Gene analysis of glucose-6-phosphatase, catalytic subunit, common variants involves studying specific genes related to glucose metabolism. This helps understand if you're at risk of certain metabolic disorders. It's a non-invasive procedure, involving a simple blood or saliva sample.

This service was performed 32 times for 32 patients

Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis

Gene analysis for glucose-6-phosphate dehydrogenase (G6PD) involves studying your DNA to check for changes in the G6PD gene. This gene controls an enzyme that helps red blood cells function properly. Anomalies can cause health issues like anemia.

This service was performed 52 times for 52 patients

Gene analysis (hexosaminidase a) common variants

Gene analysis of Hexosaminidase A common variants is a test that examines your DNA for changes in the Hex A gene. This gene is responsible for making an enzyme that breaks down certain substances in the body. Changes in this gene can lead to health issues.

This service was performed 16 times for 16 patients

Gene analysis (janus kinase 2) targeted sequence analysis

Gene analysis, specifically Janus Kinase 2 (JAK2) targeted sequence analysis, is a lab test that studies a specific gene in your body. It helps identify changes or mutations in the JAK2 gene, which can be linked to certain health conditions. This analysis is performed on a blood or bone marrow sample.

This service was performed 35 times for 35 patients

Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10

Gene analysis of the MPL proto-oncogene, thrombopoietin receptor, specifically sequence analysis of exon 10, is a procedure that studies a specific part of your DNA. It helps to identify any changes or mutations that may contribute to certain blood disorders.

This service was performed 35 times for 35 patients

Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis

Gene analysis (MUTYH) full sequence analysis is a test that examines your DNA to identify any changes linked to nonpolyposis colon cancer type 1. This can help determine your risk of developing this type of cancer.

This service was performed 44 times for 44 patients

Gene analysis (muts homolog 6 [e coli]) full sequence analysis

Gene analysis, specifically MUTS Homolog 6 (E. coli) full sequence analysis, is a test that examines your DNA to identify changes in the MUTS Homolog 6 gene. This information helps doctors understand and manage potential health concerns.

This service was performed 76 times for 76 patients

Gene analysis (partner and localizer of brca2) full sequence analysis

Gene analysis, specifically for the partner and localizer of BRCA2, involves examining your genetic code to identify any changes in this particular gene. This gene is significant in maintaining the health of your cells. The full sequence analysis means we look at every part of this gene to ensure it's working properly.

This service was performed 76 times for 74 patients

Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis

Gene analysis, specifically postmeiotic segregation increased 2 (s cerevisiae) full sequence analysis, is a scientific procedure. It involves studying your entire genetic code to identify any changes or differences that could be related to certain health conditions. This is done in a lab, using a sample provided by you.

This service was performed 99 times for 99 patients

Gene analysis (solute carrier organic anion transporter family, member 1b1) for common variant

Gene analysis for the solute carrier organic anion transporter family, member 1b1 (SLCO1B1), common variant, is a test that examines your DNA to identify variations in the SLCO1B1 gene. This gene plays a crucial role in the body's ability to process certain medications.

This service was performed 86 times for 86 patients

Gene analysis (v-ki-ras2 kirsten rat sarcoma viral oncogene) variants in codons 12 and 13

Gene analysis for v-ki-ras2 kirsten rat sarcoma viral oncogene variants in codons 12 and 13 is a test to identify specific changes in your genes. These changes could potentially indicate a higher risk for certain types of cancer.

This service was performed 18 times for 18 patients

Gene analysis (v-raf murine sarcoma viral oncogene homolog b1)

Gene analysis of v-raf murine sarcoma viral oncogene homolog b1 (BRAF) is a test that examines your DNA to identify changes or mutations in the BRAF gene. This information can help in diagnosing and treating certain diseases, including some types of cancer.

This service was performed 18 times for 18 patients

Gene analysis for cancer (neuroblastoma)

Gene analysis for neuroblastoma is a test that studies your genes to identify abnormalities linked to this type of cancer. It helps doctors tailor treatment plans, potentially improving outcomes and reducing side effects.

This service was performed 18 times for 18 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within

This is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.

This service was performed 17 times for 17 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r

This is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.

This service was performed 17 times for 17 patients

Insertion of needle into vein for collection of blood sample

This procedure involves inserting a small needle into a vein, typically in your arm, to collect a blood sample. It's a quick and simple process to help diagnose or monitor health conditions. You may feel a small prick, but discomfort is minimal.

This service was performed 11 times for 11 patients

Manual urinalysis test with examination using microscope, automated

A manual urinalysis test with automated microscopic examination is a lab process that checks your urine for health indicators. It involves a machine scanning your sample to identify any abnormal elements, which can assist in diagnosing various conditions.

This service was performed 23 times for 22 patients

Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody

This procedure checks for antibodies to the COVID-19 virus in your blood. It indicates whether you've had a past infection. The body produces these antibodies while fighting off the virus. It's not a test for current infection.

This service was performed 14 times for 14 patients

Molecular pathology procedure level 4

A Molecular Pathology Procedure Level 4 is a sophisticated lab test that analyzes your DNA. It helps identify specific genetic changes that may be causing or increasing the risk of certain diseases. This understanding can aid in diagnosis, treatment, and prevention strategies.

This service was performed 22 times for 22 patients

Molecular pathology procedure level 5

A Molecular Pathology Procedure Level 5 is a complex lab test that studies genes and proteins at a molecular level. It helps identify genetic changes or infections that may cause or influence disease. This information is crucial for diagnosis and treatment planning.

This service was performed 69 times for 28 patients

Molecular pathology procedure level 6 genetic analysis

A molecular pathology procedure level 6 genetic analysis is a complex lab test. It examines your DNA to identify specific genetic changes that can cause or increase the risk of disease. Understanding these changes can help in tailoring treatments.

This service was performed 30 times for 15 patients

Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source

Specimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.

This service was performed 16 times for 16 patients

Test for detecting genes associated with colon cancer, genomic sequence analysis panel, at least 10 genes

This is a genetic test that checks for specific genes linked to colon cancer. The test analyzes a minimum of 10 genes to identify any changes or mutations that may increase the risk of developing this type of cancer.

This service was performed 32 times for 32 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
06D2173555
Facility Type
Independent
Certificate Effective Date
December 29, 2023
Certificate Expiration Date
December 28, 2025
Laboratory Director
DR. PATRICIA BAKER
Certificate Type
Certificate of Accreditation
Certificate Type Description
This is a CLIA certificate is issued to Global Reach Labs, Llc on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.

Reviews for GLOBAL REACH LABS, LLC

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1174167597, we treat the final digit (7) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 63. The final step is to find the difference between that total and the next multiple of ten (70 - 63 = 7).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
1
Unchanged
Pos 3
7
Doubled → 14 → 1 + 4
Pos 4
4
Unchanged
Pos 5
1
Doubled → 2
Pos 6
6
Unchanged
Pos 7
7
Doubled → 14 → 1 + 4
Pos 8
5
Unchanged
Pos 9
9
Doubled → 18 → 1 + 8
Check
7
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 7 → 14 → 5 1 → 2 7 → 14 → 5 9 → 18 → 9

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 1 + 1 + 4 + 4 + 2 + 6 + 1 + 4 + 5 + 1 + 8 + 24 = 63

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 63 is 70. The difference is the calculated check digit.

70 - 63 = 7
This NPI is valid
The calculated check digit is 7, which matches the last digit of 1174167597.

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1174167597, enumerated as an "organization" on October 29, 2019.

The provider is located at 3400 E BAYAUD AVE STE 280 DENVER, CO 80209 and the phone number is (561) 373-0577.

Clinical Medical Laboratory with taxonomy code 291U00000X.